News

Angelika Lahnsteiner

Frühzeitige Behandlung von Stoffwechselkrankheiten senkt Krebsrisiko

Dr. Angelika Lahnsteiner vom Fachbereich Biowissenschaften und Medizinische Biologie der PLUS hat einen möglichen Zusammenhang zwischen metabolischen Erkrankungen und dem damit verbundenen erhöhten Krebsrisiko untersucht. Diese Experimente wurden durch den neuen Early Career Grant der PLUS gefördert.

Veröffentlicht am 04 September 2024
Picture 1 - Nikolaus Fortelny & Christoph Bock (c) Klaus Pichler_CeMM

Immune cells in the starting blocks: Being “always ready” is hard work – Nature Immunology paper by CTBI-PI Nikolaus Fortelny

When pathogens invade the body, the immune system must respond immediately to prevent or contain infection. But how do our immune cells stay ready when there is no attacker in sight? Scientists in Vienna and Salzburg have come up with a fascinating explanation: They are stimulated by healthy tissue. This means that they never come to rest and are immediately ready for action when needed. This finding could be used in the future to develop drugs that specifically increase the alertness of our immune system.

The study was published in the journal Nature Immunology, DOI:  https://doi.org/10.1038/s41590-024-01804-1 

Veröffentlicht am 29 April 2024
Nikolaus Fortelny

Publication in Nature Communications

2023-06-27 · In a collaboration with the St. Anna Children’s Cancer Research Institute, Vienna, the Computational Systems Biology Group has unraveled the role of monocytes in neuroblastoma bone marrow metastasis using single-cell RNA and ATAC sequencing. The open access publication is available here. Also read our press release.

Veröffentlicht am 03 Januar 2024